3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
874
Precursor Cell Lymphoblastic Leukemia-Lymphoma
499
Hematologic Neoplasms
462
Leukemia, Lymphocytic, Chronic, B-Cell
388
Leukemia
328
Myelodysplastic Syndromes
324
Lymphoma
203
Lymphoma, Non-Hodgkin
191
Multiple Myeloma
145
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
139
Recurrence
136
Neoplasms
133
Leukemia, Myelomonocytic, Chronic
110
Burkitt Lymphoma
92
Lymphoma, Mantle-Cell
91
Lymphoma, Follicular
91
Lymphoma, Large B-Cell, Diffuse
88
Myeloproliferative Disorders
84
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
81
Leukemia, Biphenotypic, Acute
79
Lymphoma, B-Cell, Marginal Zone
75
Hodgkin Disease
72
Lymphoma, B-Cell
64
Waldenstrom Macroglobulinemia
54
Primary Myelofibrosis
53
Leukemia, B-Cell
50
Anemia, Refractory, with Excess of Blasts
45
Leukemia, Myeloid, Chronic-Phase
40
Hematologic Diseases
37
Lymphoma, T-Cell
32
Interventions
posaconazole
1
Fluconazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Candidiasis
×
Other hematologic neoplasm
×
1 year
×
Clear all
NCT03828773
2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA
Recruiting
410 enrolled